Richard Calhoun, DPM
Foot & Ankle Surgery · Middlesboro, KYNPI 1043653041
Payments from drug & device makers
Across 47 payments — averaging $42.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$813
- Boston Scientific$453
- Averitas Pharma Inc.$130
- Rikco International, LLC$85
- Smith+Nephew$67
- Pacira Pharmaceuticals Incorporated$38
- plus $425 from 20 others
What the payments were for
- Travel & lodging$44022%
- Food & beverage$1,48674%
- Education$854%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 5 | $813 |
| Boston Scientific | 4 | $453 |
| Averitas Pharma Inc. | 7 | $130 |
| Rikco International, LLC | 2 | $85 |
| Smith+Nephew | 4 | $67 |
| Pacira Pharmaceuticals Incorporated | 2 | $38 |
| Exact Sciences | 2 | $35 |
| Cvrx, Inc. | 1 | $34 |
| Madrigal Pharmaceuticals | 2 | $33 |
| Melinta Therapeutics, LLC | 2 | $30 |
| AstraZeneca | 1 | $29 |
| Organogenesis Inc. | 1 | $25 |
| Ardelyx, Inc. | 1 | $22 |
| Vertex | 1 | $21 |
| Treace Medical Concepts, Inc. | 1 | $20 |
| Bayer | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Polynovo North America LLC | 1 | $18 |
| AbbVie | 1 | $17 |
| Corcept Therapeutics | 1 | $17 |
| Merck | 1 | $16 |
| Bioventus LLC | 1 | $16 |
| Reprise Biomedical, Inc. | 1 | $15 |
| Aroa Biosurgery Incorporated | 1 | $14 |
| ERMI LLC | 1 | $14 |
| Dynasplint Systems Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UNIVERSAL NEURO 3$440
- AUGMENT INJECTABLE$170
- EASYFUSE$165
- ANGIOJET$122
- VENOUS WALLSTENT$117
- GENERAL THROMBECTOMY$113
- GENERAL ATHERECTOMY$101
How this compares
$2,010 in reported general payments places this provider in the 40th percentile of 141 foot & ankle surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 188 | $7,966 |
| SantylCollagenase Clostridium Hist. | 14 | $4,053 |
| Ketoconazole | 73 | $1,921 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 62 | $1,263 |
| Diclofenac Sodium | 74 | $1,087 |
| Mupirocin | 100 | $692 |
| Doxycycline Hyclate | 55 | $563 |
| Colchicine | 12 | $318 |
| Cephalexin | 36 | $240 |
| Clindamycin Hcl | 13 | $99 |
| Methylprednisolone | 11 | $66 |
| Allopurinol | 23 | $64 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $46 |
| Meloxicam | 41 | $46 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $67 | $4,05314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 141 foot & ankle surgery providers in Kentucky.
Other foot & ankle surgery in Middlesboro
- William Adams IiPaducah$485K
- Sofie PinneyCynthiana$130K
- Carl KihmLouisville$89K
- Bradford FineLexington$82K
- Nicholas LacoLouisville$60K
- Jay LechnerLouisville$29K
- Russell BakerCarrollton$27K
- William McGloneLouisville$26K
- Timothy FordLouisville$26K
- Garrett WiremanLouisville$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.